Navigation Links
Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Date:12/18/2007

and 10-Q. Except as may be required by Italian law, CTI is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Susan Callahan

T: 206.272.4472

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009).... 5 Imagenetix, Inc. (OT...iam Spencer, President and CEO of Imagenetix, will...al LD MICRO Conference on Thursday, December 3rd, ... ,, About LD MICRO ,, LD MICRO is a by-invit... undervalued companies in the micro-cap space. Sin...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
(Date:11/5/2009)..., Nov. 5 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/5/2009)...xas, Nov. 5 Wound Manage...hat it has entered into a Letter of Intent to purc...th Technologies, Inc. (OTC Bulletin Board: VHGI). ...n cash and debt, 4,000,000 shares of WNDM and a ro...the Veriscrip technology being acquired from VHGI....
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...4 Advanced Medical Specialties, a,47-physician on... today,announced that it has entered into an agree...al Specialties is one of the largest oncology,prac...care environment, we believe joining the,US Oncolo...to continue,delivering the highest quality, state-...
..., Jan. 23 According to a recent College,of Pharma...ver-the-counter,product for minor wound care is su...MRSA, including the virulent strain USA300. Scient...er-the-counter wound care treatments for,effective...SA. Breaks in,the skin, such as cuts and scrapes, ...
...an. 23 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: Z...ced,today it will be participating in the Wachovia...n January 30, 2008, at 10:15 a.m. Eastern Time., ... via Zimmer,s,Investor Relations website at http:...ed for replay following the conference., About th...
Other Biology Technology:Advanced Medical Specialties Joins US Oncology Network 2Advanced Medical Specialties Joins US Oncology Network 3Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections 2Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections 3
(Date:11/8/2009)... 2009) The loss of a gene through deletion of gen...significant abnormalities in learning and behavior...ollege of Medicine ( www.bcm.edu ) in a report tha...tics . , "This research goes about 95 percent of...roup of individuals to this gene," said Dr. Arthur...
(Date:11/6/2009)...nerally live in harmony with their arboreal hosts....of space in their trees of choice, the ants can ge...ch, published in the November issue of the Americ... bore into live trees, and it reopens a centuries-...ants. , Ants and certain species of plants and t...
(Date:11/5/2009)...rchers at Yale University have developed synthetic...response to HIV and HIV-infected cells, as well as...ed online in the Journal of the American Chemical...hes for these diseases. , The molecules called...-H) and "antibody-recruiting molecule targeting pr...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Ganeden Biotech Introduces the First Probiotic Thin Strip 14053 1Ganeden Biotech Introduces the First Probiotic Thin Strip 14053 2Ganeden Biotech Introduces the First Probiotic Thin Strip 14053 3For Hispanics a Unique Cancer Profile Emerges 57176 1For Hispanics a Unique Cancer Profile Emerges 57176 2For Hispanics a Unique Cancer Profile Emerges 57176 3Patients Get Free Text or Email Prescription Medication Reminders From FreeRxReminder com 57171 1Patients Get Free Text or Email Prescription Medication Reminders From FreeRxReminder com 57171 2Patients Get Free Text or Email Prescription Medication Reminders From FreeRxReminder com 57171 3
...magine new treatments for heart disease or muscle ... rather than helping it cope with a weakened condi...earchers, who for the first time, have developed a...ls necessary for tissue repair and can be directly...blished online in The FASEB Journal ( http://www...
...n his book, Wonderful World, Stephen Jay Gould wri... wherein one could go back in time, let the tape o... at all like the original,. Evolutionary biology t...e of evolution is contingent on everything that ca...kian de Cincia (IGC) in Portugal, New York Univers...
...erkeley -- Researchers at the University of Califo...plays a far more important role than expected in c... be published Jan. 11 in the journal Nature Medic...his enzyme disabled remained lean despite eating a...s appetite. , "We have discovered a new enzyme wi...
Other Biology News:'Smart scaffolds' may help heal broken hearts 2Reverse evolution in real-time 2Disabling enzyme allows mice to gorge without becoming obese, new study finds 2Disabling enzyme allows mice to gorge without becoming obese, new study finds 3
DNA Polymerase I, E. coli from EPICENTRE Biotechnologies
...ce: E. coli strain containing an overproducing cl...e Transcriptase catalyzes the polymerization of DN...ull-length copies of large mRNAs, >10 kb, may be s... lower RNase H activity than AMV Reverse Transcrip...
...Polymerase I catalyzes the template-directed polym...direction. DNA Polymerase I possesses a 3?5 exonuc...owers the error rate during DNA replication, and a...bles the enzyme to replace nucleotides in the grow...
T4 RNA Ligase from Roche Applied Science
Biology Products: